These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22730431)

  • 21. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach.
    Xiao X; Min JL; Lin WZ; Liu Z; Cheng X; Chou KC
    J Biomol Struct Dyn; 2015; 33(10):2221-33. PubMed ID: 25513722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-target interaction prediction using unifying of graph regularized nuclear norm with bilinear factorization.
    Sorkhi AG; Abbasi Z; Mobarakeh MI; Pirgazi J
    BMC Bioinformatics; 2021 Nov; 22(1):555. PubMed ID: 34789169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of drug target groups based on chemical-chemical similarities and chemical-chemical/protein connections.
    Chen L; Lu J; Luo X; Feng KY
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):207-13. PubMed ID: 23732562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting drug-target interactions using probabilistic matrix factorization.
    Cobanoglu MC; Liu C; Hu F; Oltvai ZN; Bahar I
    J Chem Inf Model; 2013 Dec; 53(12):3399-409. PubMed ID: 24289468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DINIES: drug-target interaction network inference engine based on supervised analysis.
    Yamanishi Y; Kotera M; Moriya Y; Sawada R; Kanehisa M; Goto S
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W39-45. PubMed ID: 24838565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Drug-Target Interactions With Multi-Information Fusion.
    Peng L; Liao B; Zhu W; Li Z; Li K
    IEEE J Biomed Health Inform; 2017 Mar; 21(2):561-572. PubMed ID: 26731781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting drug-target interactions using restricted Boltzmann machines.
    Wang Y; Zeng J
    Bioinformatics; 2013 Jul; 29(13):i126-34. PubMed ID: 23812976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Drug-Target Interactions Based on Small Positive Samples.
    Hu P; Chan KCC; Hu Y
    Curr Protein Pept Sci; 2018; 19(5):479-487. PubMed ID: 27829343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kernelized Bayesian Matrix Factorization.
    Gönen M; Kaski S
    IEEE Trans Pattern Anal Mach Intell; 2014 Oct; 36(10):2047-60. PubMed ID: 26352634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction.
    Liu Y; Wu M; Miao C; Zhao P; Li XL
    PLoS Comput Biol; 2016 Feb; 12(2):e1004760. PubMed ID: 26872142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SELF-BLM: Prediction of drug-target interactions via self-training SVM.
    Keum J; Nam H
    PLoS One; 2017; 12(2):e0171839. PubMed ID: 28192537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using compound similarity and functional domain composition for prediction of drug-target interaction networks.
    Chen L; He ZS; Huang T; Cai YD
    Med Chem; 2010 Nov; 6(6):388-95. PubMed ID: 21054276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures.
    Cao DS; Liu S; Xu QS; Lu HM; Huang JH; Hu QN; Liang YZ
    Anal Chim Acta; 2012 Nov; 752():1-10. PubMed ID: 23101647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.
    Bolgár B; Antal P
    BMC Bioinformatics; 2017 Oct; 18(1):440. PubMed ID: 28978313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
    Cases M; Mestres J
    Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracting sets of chemical substructures and protein domains governing drug-target interactions.
    Yamanishi Y; Pauwels E; Saigo H; Stoven V
    J Chem Inf Model; 2011 May; 51(5):1183-94. PubMed ID: 21506615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using bioinformatics for drug target identification from the genome.
    Jiang Z; Zhou Y
    Am J Pharmacogenomics; 2005; 5(6):387-96. PubMed ID: 16336003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some Remarks on Prediction of Drug-Target Interaction with Network Models.
    Zhang SW; Yan XY
    Curr Top Med Chem; 2017; 17(21):2456-2468. PubMed ID: 28413948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.